Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease.

Dürkop H, Latza U, Hummel M, Eitelbach F, Seed B, Stein H.

Cell. 1992 Feb 7;68(3):421-7.

PMID:
1310894
2.

CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF.

Smith CA, Gruss HJ, Davis T, Anderson D, Farrah T, Baker E, Sutherland GR, Brannan CI, Copeland NG, Jenkins NA, et al.

Cell. 1993 Jul 2;73(7):1349-60.

PMID:
8391931
3.

Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen.

Oehm A, Behrmann I, Falk W, Pawlita M, Maier G, Klas C, Li-Weber M, Richards S, Dhein J, Trauth BC, et al.

J Biol Chem. 1992 May 25;267(15):10709-15.

4.
5.

Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor.

Loetscher H, Pan YC, Lahm HW, Gentz R, Brockhaus M, Tabuchi H, Lesslauer W.

Cell. 1990 Apr 20;61(2):351-9.

PMID:
2158862
7.
8.

Cloning and characterization of a cDNA for rat CD30 homolog and chromosomal assignment of the genomic gene.

Aizawa S, Satoh H, Horie R, Ito K, Choi SH, Takeuchi H, Watanabe T.

Gene. 1996 Dec 5;182(1-2):155-62.

PMID:
8982082
9.

The human OX40 homolog: cDNA structure, expression and chromosomal assignment of the ACT35 antigen.

Latza U, Dürkop H, Schnittger S, Ringeling J, Eitelbach F, Hummel M, Fonatsch C, Stein H.

Eur J Immunol. 1994 Mar;24(3):677-83.

PMID:
7510240
12.

Expression and structure of the human NGF receptor.

Johnson D, Lanahan A, Buck CR, Sehgal A, Morgan C, Mercer E, Bothwell M, Chao M.

Cell. 1986 Nov 21;47(4):545-54.

PMID:
3022937
13.
14.

A variant CD30 protein lacking extracellular and transmembrane domains is induced in HL-60 by tetradecanoylphorbol acetate and is expressed in alveolar macrophages.

Horie R, Ito K, Tatewaki M, Nagai M, Aizawa S, Higashihara M, Ishida T, Inoue J, Takizawa H, Watanabe T.

Blood. 1996 Oct 1;88(7):2422-32.

15.

Structure and expression of murine CD30 and its role in cytokine production.

Bowen MA, Lee RK, Miragliotta G, Nam SY, Podack ER.

J Immunol. 1996 Jan 15;156(2):442-9.

PMID:
8543792
17.

Opposite effects of the CD30 ligand are not due to CD30 mutations: results from cDNA cloning and sequence comparison of the CD30 antigen from different sources.

Jung W, Krueger S, Renner C, Gause A, Sahin U, Trümper L, Pfreundschuh M.

Mol Immunol. 1994 Dec;31(17):1329-34.

PMID:
7527901
18.

Characterization of a chimeric T-cell receptor with specificity for the Hodgkin's lymphoma-associated CD30 antigen.

Hombach A, Heuser C, Sircar R, Tillmann T, Diehl V, Pohl C, Abken H.

J Immunother. 1999 Nov;22(6):473-80.

PMID:
10570745
19.

The T cell activation antigen CD27 is a member of the nerve growth factor/tumor necrosis factor receptor gene family.

Camerini D, Walz G, Loenen WA, Borst J, Seed B.

J Immunol. 1991 Nov 1;147(9):3165-9.

PMID:
1655907
20.

Supplemental Content

Support Center